News Archive

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC)

11th September 2019

Includes agenda and Sept 2019 PRAC statistics

Read More+

MHRA: Brexit No-Deal Update

9th September 2019

The MHRA have updated their guidelines on how you can continue to submit regulatory and notification information to the UK.

Read More+

EMA publishes first two Guidances on Drug Shortages

4th September 2019

Regulators in the European Union have taken first steps to diminish shortages of medicinal products. The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) published two guidance documents which can be seen as foundation or first step for a long way: how to define and how to communicate drug shortages.

Read More+

Global public meeting on draft ICH guideline on clinical trials

4th September 2019

The global guidance for the conduct of clinical trials is currently undergoing a major revision. As part of the worldwide consultation process, the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is organising a public meeting to review its draft E8 (R1) Guideline ‘General Considerations for Clinical Trials’. EMA is encouraging its stakeholders to register for this meeting, which will be held on 31 October 2019 at the United States Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland, United States of America. Participants will be able to attend in person or via webcast.

Read More+

EMA/FDA analysis - Alignment of Decisions

21st August 2019

EMA/FDA analysis shows high degree of alignment in marketing application decisions between EU and US.

Read More+

Questions and Answers on Current GMP—Laboratory Controls

21st August 2019

The FDA has recently added three new questions to its Q&A section on cGMP in the Quality Control Laboratory (chromatography systems and describe FDA's perception of basic cGMP principles in chromatographic procedures).

Read More+

Falsified Medicines and the supply chain

13th August 2019

MHRA Blog post by Tracy Moore, 8th August.

Read More+

MHRA Update to regulations if there is a no deal Brexit

13th August 2019

Further guidance note on the regulation of medicines, medical devices and clinical trials if there’s no Brexit deal - Updated 8 August 2019

Read More+

Protecting Public Health - Article

13th August 2019

Dr Ian Hudson, CEO, Medicines and Healthcare products Regulatory Agency (MHRA) spoke with Viveka Roychowdhury on how the Agency is working with pharmaceutical companies to increase compliance with Good Manufacturing Practices (GMP) as well as preparing for Brexit and beyond. Read the full article.

Read More+

Updated - Blue Guide: advertising and promoting medicines

13th August 2019

Detailed guidance on advertising and promoting medicines - updated 12th August 2019.

Read More+